Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.470
-0.030 (-2.00%)
At close: Aug 12, 2025, 4:00 PM
1.470
0.00 (0.00%)
Pre-market: Aug 13, 2025, 7:03 AM EDT
Satixfy Communications Market Cap
Compugen has a market cap or net worth of $137.50 million as of August 13, 2025. Its market cap has decreased by -13.20% in one year.
Market Cap
137.50M
Enterprise Value
46.59M
1-Year Change
-13.20%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since December 31, 2002, Compugen's market cap has increased from $46.50M to $137.50M, an increase of 195.69%. That is a compound annual growth rate of 4.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2025 | 137.50M | 0.36% |
Dec 31, 2024 | 137.00M | -21.58% |
Dec 29, 2023 | 174.70M | 181.77% |
Dec 30, 2022 | 62.00M | -82.82% |
Dec 31, 2021 | 360.80M | -64.38% |
Dec 31, 2020 | 1.01B | 183.96% |
Dec 31, 2019 | 356.70M | 220.49% |
Dec 31, 2018 | 111.30M | -12.91% |
Dec 29, 2017 | 127.80M | -50.45% |
Dec 30, 2016 | 257.90M | -19.68% |
Dec 31, 2015 | 321.10M | -5.97% |
Dec 31, 2014 | 341.50M | 4.27% |
Dec 31, 2013 | 327.50M | 91.74% |
Dec 31, 2012 | 170.80M | 1.73% |
Dec 30, 2011 | 167.90M | 3.83% |
Dec 31, 2010 | 161.70M | 16.92% |
Dec 31, 2009 | 138.30M | 1,033.61% |
Dec 31, 2008 | 12.20M | -72.95% |
Dec 31, 2007 | 45.10M | -37.45% |
Dec 29, 2006 | 72.10M | -38.95% |
Dec 30, 2005 | 118.10M | -14.61% |
Dec 31, 2004 | 138.30M | 4.38% |
Dec 31, 2003 | 132.50M | 184.95% |
Dec 31, 2002 | 46.50M | - |
Dec 31, 2002 | 46.50M | - |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 570.26B |
Johnson & Johnson | 418.62B |
AbbVie | 350.91B |
AstraZeneca | 229.47B |
UnitedHealth Group | 228.94B |
Novartis AG | 228.69B |
Abbott Laboratories | 228.63B |
Novo Nordisk | 222.88B |